Vaccination against autoimmune encephalomyelitis (EAE): Attenuated autoimmune T lymphocytes confer resistance to induction of active EAE but not to EAE mediated by the intact T lymphocyte line

No abstract is available for this paper.

• Publication year

  1981

• Venue

  European Journal of Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/eji.1830111119PMID 7327196
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The rapid isolation of clonable antigen‐specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis

  1981cited by this paper
• Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein

  1981cited by this paper
• Spontaneous remission of autoimmune encephalomyelitis is inhibited by splenectomy, thymectomy or ageing

  1980cited by this paper
• In vitro generation of tumor-specific cytotoxic lymphocytes. Secondary allogeneic mixed tumor lymphocyte culture of normal murine spleen cells

  1977cited by this paper
• Specific transplantation tolerance induced by autoimmunization against the individual's own, naturally occurring idiotypic, antigen-binding receptors

  1976cited by this paper
• Cellular events in the induction of experimental allergic encephalomyelitis in rats

  1976cited by this paper
• Antigen-induced inhibition of experimental allergic encephalomyelitis. III. Localization of an inhibitory site distinct from the major encephalitogenic determinant of myelin basic protein.

  1975cited by this paper
• Basic encephalitogenic protein: A simplified purification on sulphoethyl‐sephadex

  1970cited by this paper
• Experimental Allergic Encephalomyelitis: Synthesis of Disease-Inducing Site of the Basic Protein

  1970cited by this paper
• Various Types of Acquired Resistance to Experimental ‘Allergic’ Encephalomyelitis

  1959cited by this paper

• Tolerogenic probiotics and gut-brain axis: targeting pain receptors in neuroimmune disorders

  2025cites this paper
• A genome-wide in vivo CRISPR screen identifies essential regulators of T cell migration to the CNS in a multiple sclerosis model

  2023cites this paper
• The effect of UVA light/8-methoxypsoralen exposure used in Extracorporeal Photopheresis treatment on platelets and extracellular vesicles

  2023cites this paper
• Identification of essential modules regulating T cell migration to the central nervous system in multiple sclerosis

  2022cites this paper
• Gut instincts in neuroimmunity from the eighteenth to twenty-first centuries

  2022cites this paper
• Timing Effect of Adenosine-Directed Immunomodulation on Mouse Experimental Autoimmune Uveitis

  2021cites this paper
• The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity

  2020cites this paper
• The immune regulation of PD-1/PDL-1 axis, a potential biomarker in multiple sclerosis

  2020cites this paper
• Neuroimmunology – the past, present and future

  2019cites this paper
• Intradermal vaccination prevents anti-MOG autoimmune encephalomyelitis in macaques

  2019cites this paper
• Circulating Picomolar Levels of CCL2 Downregulate Ongoing Chronic Experimental Autoimmune Encephalomyelitis by Induction of Regulatory Mechanisms

  2019cites this paper
• HWU et al. “Lysis of Ovarian Cancer Cells by Human Lymphocytes Redirected with a Chimeric Gene Composed of an Antibody Vari

  2017cites this paper
• Regulatory Role of Peritoneal B Cells in EAE

  2016cites this paper
• The rational targeting of the DNA damage response pathway for the selective elimination of encephalitogenic T cells

  2015cites this paper
• Cerebral Biochemical Pathways in Experimental Autoimmune Encephalomyelitis and Adjuvant Arthritis: A Comparative Metabolomic Study

  2013cites this paper
• Role of meningeal inflammation in cortical pathology and disease progression of multiple sclerosis

  2013cites this paper
• Targeting growth factors to sites of inflammation:gene therapy for multiple sclerosis.

  2012cites this paper
• Multiple Sklerose und andere autoimmune ZNS-Erkrankungen

  2012cites this paper
• Behandlung mit CDK5 Inhibitor bei der Myelin Oligodendrozyten Glykoprotein (MOG) induzierten experimentellen autoimmunen Encephalomyelitis (EAE)

  2011cites this paper
• Étude des mécanismes d'action de la PhotoChimiothérapie Extra-corporelle chez l'Homme

  2010cites this paper
• Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelination

  2010cites this paper
• Clone clusters in autoreactive CD4 T‐cell lines from probable multiple sclerosis patients form disease‐characteristic signatures

  2009cites this paper
• HLA-DQB 1 * 0602 Determines Disease Susceptibility in a New “ Humanized ” Multiple Sclerosis Model in HLA-DR 15 ( DRB 1 * 1501 ; DQB 1 * 0602 ) Transgenic Mice 1

  2009cites this paper
• HLA-DQB1*0602 Determines Disease Susceptibility in a New “Humanized” Multiple Sclerosis Model in HLA-DR15 (DRB1*1501;DQB1*0602) Transgenic Mice1

  2009cites this paper
• Interplay Between Effector Th17 and Regulatory T Cells

  2008cites this paper
• Role of Th1 and Th17 cells in organ-specific autoimmunity.

  2008cites this paper
• CD4+CD25+ Regulatory T Cells as Adoptive Cell Therapy for Autoimmune Disease and for the Treatment of Graft-Versus-Host Disease

  2008cites this paper
• Novel therapeutic strategies for multiple sclerosis — a multifaceted adversary

  2008cites this paper
• Multiple sclerosis therapy: An update on recently finished trials

  2007cites this paper
• Multiple-Sklerose-Update zur Pathophysiologie und neuen immuntherapeutischen Ansätzen

  2007cites this paper
• [Update on pathophysiologic and immunotherapeutic approaches for the treatment of multiple sclerosis].

  2007cites this paper
• TCR vaccination in aluminum adjuvant protects against autoimmune encephalomyelitis.

  2006cites this paper
• Antigen-Specific Therapies in Multiple Sclerosis

  2005cites this paper
• T-cell vaccination in multiple sclerosis.

  2004cites this paper
• Mechanism of self-tolerance to endocrine tissue

  2004cites this paper
• T cell vaccination in multiple sclerosis relapsing-remitting nonresponders patients.

  2004cites this paper
• Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines

  2004cites this paper
• Development of CD4+ T cell lines that suppress an antigen‐specific immune response in vivo

  2003cites this paper
• Chapter 11 Multiple Sclerosis

  2001cites this paper
• T cell receptor peptides for the vaccination therapy of multiple sclerosis.

  2000cites this paper
• Modeling the influence of TH1- and TH2-type cells in autoimmune diseases.

  2000cites this paper
• Serum IgM repertoire reactions to MBP/CFA immunization reflect the individual status of EAE susceptibility.

  2000cites this paper
• Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein‐specific Th2 cell lines generated in the presence of glucocorticoids and IL‐4

  2000cites this paper
• Perspectives on T cell receptor expression in autoimmune disease.

  1999cites this paper
• Regulatory T cells in experimental allergic encephalomyelitis. II. T cells functionally antagonistic to encephalitogenic MBP‐specific T cells show persistent expression of FasL

  1999cites this paper
• Regulatory T cells in experimental allergic encephalomyelitis. I. Frequency and specificity analysis in normal and immune rats of a T cell subset that inhibits disease.

  1999cites this paper
• Immunotherapies for Multiple Sclerosis

  1999cites this paper
• Usage of Vbeta3.3 T-cell receptor by myelin basic protein-specific encephalitogenic T-cell lines in the Lewis rat.

  1999cites this paper
• From Basic Immunology to Immune-Mediated Demyelination

  1999cites this paper
• Local delivery of cytokines by retrovirally transduced antigen-specific TCR+ hybridoma cells in experimental autoimmune encephalomyelitis.

  1998cites this paper
• Immunomodulating therapeutic approaches for multiple sclerosis.

  1998cites this paper
• Diversity of the anti-T-cell receptor immune response and its implications for T-cell vaccination therapy of multiple sclerosis.

  1998cites this paper
• Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives.

  1997cites this paper
• Experimental allergic encephalomyelitis and vaccination-induced resistance in DA rats.

  1997cites this paper
• Acquired resistance to experimental autoimmune encephalomyelitis is independent of V beta usage.

  1997cites this paper
• Active immunization with complementary peptide PBM 9‐1: preliminary evidence that it modulates experimental allergic encephalomyelitis in PL/J mice and Lewis rats

  1996cites this paper
• T-cell vaccination prevents EAE effector cell development but does not inhibit priming of MBP responsive cells.

  1996cites this paper
• T cell receptor (TCR) V gene segment use in HLA‐typed Japanese healthy subjects

  1996cites this paper
• Vaccination with a synthetic T-cell receptor V-region peptide: immunomodulation or vaccination.

  1995cites this paper
• Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease.

  1995cites this paper
• Animal models of human disease : experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease

  1995cites this paper
• A cross-reactive idiotope on T cells from PL/J mice and Lewis rats that recognizes different myelin basic protein encephalitogenic epitopes but is restricted by TCR V beta 8.2.

  1994cites this paper
• Inoculation of BCL1 lymphoma cells into CSJL/J F1 mice inhibits acute experimental autoimmune encephalomyelitis.

  1994cites this paper
• Uveitogenic T lymphocytes in the rat: pathogenicity vs. lymphokine production, adhesion molecules and surface antigen expression.

  1994cites this paper
• Focusing on the human T cell receptor for antigen.

  1994cites this paper
• Vaccination with T cell receptor peptides primes anti‐receptor cytotoxic T lymphocytes (CTL) and anergizes T cells specifically recognized by these CTL

  1994cites this paper
• Towards T cell vaccination in rheumatoid arthritis.

  1994cites this paper
• Bromodeoxyuridine and light treatment deletes effector but not suppressor cells of autoimmune encephalomyelitis.

  1993cites this paper
• Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice.

  1993cites this paper
• Inhibition of cellular transfer of experimental autoimmune uveoretinitis by Rapamycin.

  1993cites this paper
• CHAPTER 16 – Principles of Therapeutic Approaches to Autoimmunity

  1992cites this paper
• Management of early inflammatory arthritis. Intervention with immunomodulatory agents: T cell vaccination.

  1992cites this paper
• CD4+ suppressor cells of autoimmune encephalomyelitis respond to T cell receptor‐associated determinants on effector cells by interleukin‐4 secretion

  1992cites this paper
• Intervention with immunomodulatory agents: T cell vaccination

  1992cites this paper
• Successful treatment of heart transplant rejection with photopheresis.

  1992cites this paper
• Observations, legends, and conjectures concerning restricted T-cell receptor usage and autoimmune disease.

  1992cites this paper
• Synthetic peptides representing sequence 39 to 59 of rat Vβ8 TCR fail to elicit regulatory T cells reactive with Vβ8 TCR on rat encephalitogenic T cells

  1992cites this paper
• Prevention of experimental autoimmune encephalomyelitis in Lewis rats by treatment with an anti-rat CD5 antibody (OX19).

  1992cites this paper
• Myelin basic protein–specific T lymphocytes in multiple sclerosis and controls: Precursor frequency, fine specificity, and cytotoxicity

  1992cites this paper
• Antigen-specific tolerance as a therapy for experimental autoimmune encephalomyelitis.

  1992cites this paper
• Synthetic peptides representing sequence 39 to 59 of rat V beta 8 TCR fail to elicit regulatory T cells reactive with V beta 8 TCR on rat encephalitogenic T cells.

  1992cites this paper
• Studies of Vβ8 T cell receptor peptide treatment in experimental autoimmune encephalomyelitis

  1992cites this paper
• Myelin specific, autoaggressive T cell clones in the normal immune repertoire: their nature and their regulation.

  1992cites this paper
• Studies of V beta 8 T cell receptor peptide treatment in experimental autoimmune encephalomyelitis.

  1992cites this paper
• CD4-CD8- splenic T cells from Lewis rats recovered from experimental autoimmune encephalomyelitis respond to encephalitogenic T cells that mediate this disorder.

  1991cites this paper
• Combined anti-interleukin-2 receptor and low-dose cyclosporine therapy in experimental autoimmune uveoretinitis.

  1991cites this paper
• Heterogeneity of the T-cell receptor beta gene rearrangements generated in myelin basic protein-specific T-cell clones isolated from a patient with multiple sclerosis.

  1991cites this paper
• Antigen processing and presentation by glomerular visceral epithelium in vitro.

  1991cites this paper
• T Cell Vaccination in Autoimmune Diseases

  1991cites this paper
• HgCl2-induced perturbation of the T cell network in experimental allergic encephalomyelitis. I. In vitro characterization of T cells involved.

  1991cites this paper
• [Significance of autoimmunity in various forms of uveitis].

  1991cites this paper
• T cell vaccination does not induce resistance to experimental autoimmune neuritis.

  1991cites this paper
• Adoptive transfer of experimental allergic encephalomyelitis: conditions influencing memory and effector cell development.

  1990cites this paper
• Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells).

  1989cites this paper
• Vaccination against experimental autoimmune encephalomyelitis using a subencephalitogenic dose of autoimmune effector cells (1). Characteristics of vaccination.

  1989cites this paper
• Functional heterogeneity among CD4+ encephalitogenic T cells in recruitment of CD8+ T cells in experimental autoimmune encephalomyelitis.

  1989cites this paper
• Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes.

  1989cites this paper
• Lymphocyte vaccination again t experimental autoimmune encephalomyelitis: evaluation of vaccination protocols

  1989cites this paper
• Evidence for multiple human T cell recognition sites on myelin basic protein.

  1989cites this paper
• Regulatory circuits in autoimmunity: recruitment of counter‐regulatory CD8+ T cells by encephalitogenic CD4+ T line cells

  1988cites this paper